About Endpoint Outcomes
Endpoint Outcomes is a company based in Boston (United States) founded in 2012 was acquired by Lumanity in June 2022. Endpoint Outcomes operates in a competitive market with competitors including Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Endpoint Outcomes
Detailed funding history for Endpoint Outcomes
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Endpoint Outcomes
Endpoint Outcomes has secured backing from 1 investor. Prominent investors backing the company include Lumanity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Film production services are provided by Lumanity from London.
|
Locked | Locked | Locked |
Investor details for Endpoint Outcomes
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endpoint Outcomes
Investment portfolio details for Endpoint Outcomes
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endpoint Outcomes
Detailed financials for Endpoint Outcomes
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endpoint Outcomes Comparisons
Peer comparison for Endpoint Outcomes
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endpoint Outcomes
Endpoint Outcomes operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Precision medicine integration is facilitated through analytics and services.
|
Detailed competitors of Endpoint Outcomes
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endpoint Outcomes
Complete news archive for Endpoint Outcomes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endpoint Outcomes
Endpoint Outcomes was founded in 2012.
Endpoint Outcomes is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Christopher Evans is the current CEO of Endpoint Outcomes.
Endpoint Outcomes was founded in 2012 and is headquartered in Boston, United States. Consulting services focused on clinical development, outcome validation, regulatory strategy, and related areas are delivered to clients in the biopharmaceutical sector. Operations emphasize support for drug development processes, ensuring compliance and efficacy in therapeutic advancements. Expertise is applied across various stages of biopharma projects to facilitate informed decision-making.
Endpoint Outcomes's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Endpoint Outcomes has 1 investor. Key investors include Lumanity.